Latest Ketamine Stories
NEW YORK, March 5, 2015 /PRNewswire/ -- The Journal of Drugs in Dermatology is delighted to present new findings from the Mayo Clinic's Department of Dermatology showing possible relief
Turing launches with three major product acquisitions: intranasal ketamine program, Syntocinon® Nasal Spray, and Vecamyl®; company introduces senior leadership team NEW YORK, Feb.
Today the Rett Syndrome Research Trust (RSRT) announced research investments of $5.8 million awarded in 2014.
NORWALK, Conn., Oct.
WASHINGTON, July 23, 2014 /PRNewswire-USNewswire/ -- For critically ill patients arriving at the emergency department, the drug ketamine can safely provide analgesia, sedation and amnesia for
There is new hope for people suffering from depression.
CARDIFF, Calif., May 6, 2014 /PRNewswire/ -- NI Research has released the May issue of NeuroPerspective, which features
- Lead NMDA Receptor Modulator GLYX-13 Shows Robust and Sustained Antidepressant Effects with Repeat Dosing and Is Well-Tolerated in Subjects with Difficult-to-Treat Depression - EVANSTON,
- an ornament or knob in the shape of a flower